Expert Expects T-DM1 to Transform Treatment in HER2+ Breast Cancer OncLive
Charles E. Geyer, Jrm, MD, discusses the clinical implications of the KATHERINE trial and the outlook for T-DM1 in patients with HER2-positive breast cancer.
Updates on Health News
Expert Expects T-DM1 to Transform Treatment in HER2+ Breast Cancer OncLive
Charles E. Geyer, Jrm, MD, discusses the clinical implications of the KATHERINE trial and the outlook for T-DM1 in patients with HER2-positive breast cancer.
Metastatic breast cancer in the lungs: Symptoms, treatment, and prognosis Medical News Today
Metastatic, or stage 4, breast cancer in the lungs is when breast cancer cells are growing in the lungs. In this article, we look at what happens when breast …
Cancer Research News for the Week Everyday Health
January 23, 2019. News breaks in the cancer arena all the time. Sometimes it’s big — like word that a breakthrough drug has increased survival for a …
Multifocal breast cancer: Definition, staging, prognosis, and treatment Medical News Today
Multifocal breast cancer is where a person has more than one tumor in one area of their breast. In this article, we look at the causes, diagnosis, staging, …
Moline Hy-Vee to host breast cancer research fundraiser WQAD Moline
On February 2 a local fundraiser will show you can raise money for breast cancer research while still having fun.
Putting Cancer Behind Me Curetoday.com
When I was diagnosed with breast cancer at the age of 37, my life was divided into a before and after. In the years that followed, when I recalled something, …
Dancing after breast cancer: ‘I feel like a woman again’ BBC News
After her mastectomy four years ago, ex-nurse Gail Stewart “didn’t feel like herself” until she began dancing. She is among a group of Welsh women who have …
USPSTF: Offer Medication to Reduce Breast Cancer Risk AAFP News
The U.S. Preventive Services Task Force recently issued a draft recommendation for prescribing risk-reducing medications to women at increased risk for breast …
HR+ Metastatic Breast Cancer: Upfront CDK4/6 Inhibition OncLive
The panel of experts reflect upon the potential of CDK4/6 inhibitors to improve outcomes in the frontline setting for patients with hormone receptor-positive …
New therapy turns cancer cells into fat to stop it from spreading Big Think
Researchers have developed a new drug therapy that turns cancer cells into fat cells. The new fat cells cannot divide or proliferate throughout the body.